Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Triton Systems is a private U.S. technology development company headquartered in Chelmsford, Massachusetts that applies advanced materials, systems engineering, and product-development capabilities across defense, medical, energy, and industrial markets. While the company is primarily positioned today as a defense contractor, it also maintains a Medical and Human Health business focused on diagnostics, health monitoring, therapeutics-enabling tools, and medical devices. Its health-related work has included biomarker detection tools, optoelectronic cardiac devices, chronic disease monitoring, organs-on-a-chip systems for drug discovery, and field-care or wearable medical-device concepts. Triton operates more like a diversified applied innovation and commercialization platform than a single-asset biotech company, with products, licensing activity, and spinout formation rather than a traditional drug pipeline. The company appears to be active and operating, but corporate databases indicate it was acquired by Dover in 2000 while continuing to operate under the Triton Systems name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Triton Systems.